BioSpace News Archive

Business

Abyrx® Appoints Gary D. Cohn as Director

Former Director of the U.S. National Economic Council and Goldman Sachs COO joins biomaterial sciences company Board of Directors

November 14, 2018
·
3 min read
Business

Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar’s Oncology Programs

Dr. Lin will lead development strategy and study oversight of the company’s immuno-oncology candidates and other oncology programs.

November 14, 2018
·
5 min read
Drug Development

Circulating Tumor Cells Detected From Angiosarcoma Cancer Patients With Use Of ApoStream® Technology In A First-of-its-kind Study

PROMISING RESULTS DERIVED FROM THE PIVOTAL PHASE 3 TAPPAS TRIAL OF TRC105 AND VATRIENT® IN PATIENTS WITH ADVANCED ANGIOSARCOMA.

November 14, 2018
·
3 min read
Pharm Country

Secant Group, LLC Milestone: 75th Anniversary

November 2018 marks the 75th anniversary of the company.

November 14, 2018
·
2 min read
Biotech Beach

Canon Medical Receives FDA Clearance for Premium MR System: Vantage Orian 1.5T

Canon Medical Systems USA, Inc. has received 510(k) clearance on its new premium MRI system, Vantage Orian™ 1.5T.

November 14, 2018
·
2 min read
Deals

ResMed Completes Acquisition of MatrixCare

Establishes ResMed as a leader in out-of-hospital software-as-a-service offerings

November 14, 2018
·
4 min read
Pharm Country

Revolutionary egg freezing studio, designed by women for women, launches in New York City

By creating a state-of-the-art space where women can celebrate taking charge of their futures, Trellis is rewriting the script on egg-freezing.

November 14, 2018
·
3 min read
Business

Qosina Announces the Addition of Four New Board Members

The new members join the existing board of Stuart Herskovitz, Janis Herskovitz and Scott Herskovitz.

November 14, 2018
·
3 min read
Biotech Beach

Latest Results from the I-SPY 2 Trial at the EORTC-NCI-AACR Symposium Demonstrate Ability of MammaPrint® and BluePrint® to Predict Treatment Response in Breast Cancer Patients

New data from the trial shows that a subgroup of “Ultra-High Risk” patients identified by MammaPrint respond better to certain targeted therapies and treatment combinations

November 14, 2018
·
6 min read
Biotech Bay

2019 Life Sciences Industry Report from CLSA Shows Strong Growth in Jobs, Investments and Therapeutic Pipeline in California

California’s life sciences sector continues to lead the nation in economic growth and innovative activity

November 14, 2018
·
8 min read